Hi pinto, It's a mistake to apply charting tech's to an R&D Co like MST it's only in very recent times they have had product to sell, R&D is very much like biotech's usually a very long lead time before commercialization happens, charting tech's are a usefull tool for Co's with product/services on the market for some time, MST IMHO is just about to go commercial with good products and revenue to match. This is not investment advise you have to be responsible for your own research, very important!!!! Cheers, mrdog.
MST Price at posting:
0.9¢ Sentiment: Buy Disclosure: Held